Literature DB >> 19538528

Constitutive activation of nuclear factor-kappaB is preferentially involved in the proliferation of basal-like subtype breast cancer cell lines.

Noritaka Yamaguchi1, Taku Ito, Sakura Azuma, Emi Ito, Reiko Honma, Yuka Yanagisawa, Akira Nishikawa, Mika Kawamura, Jun-ichi Imai, Shinya Watanabe, Kentaro Semba, Jun-ichiro Inoue.   

Abstract

Constitutive nuclear factor (NF)-kappaB activation is thought to be involved in survival, invasion, and metastasis in various types of cancers. However, neither the subtypes of breast cancer cells with constitutive NF-kappaB activation nor the molecular mechanisms leading to its constitutive activation have been clearly defined. Here, we quantitatively analyzed basal NF-kappaB activity in 35 human breast cancer cell lines and found that most of the cell lines with high constitutive NF-kappaB activation were categorized in the estrogen receptor negative, progesterone receptor negative, ERBB2 negative basal-like subtype, which is the most malignant form of breast cancer. Inhibition of constitutive NF-kappaB activation by expression of IkappaBalpha super-repressor reduced proliferation of the basal-like subtype cell lines. Expression levels of mRNA encoding NF-kappaB-inducing kinase (NIK) were elevated in several breast cancer cell lines, and RNA interference-mediated knockdown of NIK reduced NF-kappaB activation in a subset of the basal-like subtype cell lines with upregulated NIK expression. Taken together, these results suggest that constitutive NF-kappaB activation, partially dependent on NIK, is preferentially involved in proliferation of basal-like subtype breast cancer cells and may be a useful therapeutic target for this subtype of cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19538528     DOI: 10.1111/j.1349-7006.2009.01228.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  65 in total

1.  Triple-negative subtype predicts poor overall survival and high locoregional relapse in inflammatory breast cancer.

Authors:  Jing Li; Ana M Gonzalez-Angulo; Pamela K Allen; Tse K Yu; Wendy A Woodward; Naoto T Ueno; Anthony Lucci; Savitri Krishnamurthy; Yun Gong; Melissa L Bondy; Wei Yang; Jie S Willey; Massimo Cristofanilli; Vicente Valero; Thomas A Buchholz
Journal:  Oncologist       Date:  2011-12-06

Review 2.  The obesity-inflammation-eicosanoid axis in breast cancer.

Authors:  Linda Vona-Davis; David P Rose
Journal:  J Mammary Gland Biol Neoplasia       Date:  2013-10-30       Impact factor: 2.673

3.  α-catenin. A tumor suppressor beyond adherens junctions.

Authors:  Yutong Sun; Jinsong Zhang; Li Ma
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 4.  Inflammation fuels tumor progress and metastasis.

Authors:  Jingyi Liu; Pengnian Charles Lin; Binhua P Zhou
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

5.  Towards elucidating the connection between epithelial-mesenchymal transitions and stemness.

Authors:  Mohit Kumar Jolly; Bin Huang; Mingyang Lu; Sendurai A Mani; Herbert Levine; Eshel Ben-Jacob
Journal:  J R Soc Interface       Date:  2014-12-06       Impact factor: 4.118

6.  FOXC1 is a critical mediator of EGFR function in human basal-like breast cancer.

Authors:  Yanli Jin; Bingchen Han; Jiongyu Chen; Ruprecht Wiedemeyer; Sandra Orsulic; Shikha Bose; Xiao Zhang; Beth Y Karlan; Armando E Giuliano; Yukun Cui; Xiaojiang Cui
Journal:  Ann Surg Oncol       Date:  2014-08-15       Impact factor: 5.344

7.  Noncanonical NF-κB activation mediates STAT3-stimulated IDO upregulation in myeloid-derived suppressor cells in breast cancer.

Authors:  Jinpu Yu; Yue Wang; Fang Yan; Peng Zhang; Hui Li; Hua Zhao; Cihui Yan; Fan Yan; Xiubao Ren
Journal:  J Immunol       Date:  2014-07-25       Impact factor: 5.422

8.  Blueberry phytochemicals inhibit growth and metastatic potential of MDA-MB-231 breast cancer cells through modulation of the phosphatidylinositol 3-kinase pathway.

Authors:  Lynn S Adams; Sheryl Phung; Natalie Yee; Navindra P Seeram; Liya Li; Shiuan Chen
Journal:  Cancer Res       Date:  2010-04-13       Impact factor: 12.701

9.  FOXC1 regulates the functions of human basal-like breast cancer cells by activating NF-κB signaling.

Authors:  J Wang; P S Ray; M-S Sim; X Z Zhou; K P Lu; A V Lee; X Lin; S P Bagaria; A E Giuliano; X Cui
Journal:  Oncogene       Date:  2012-01-16       Impact factor: 9.867

10.  Strong cytoplasmic expression of NF-κB/p65 correlates with a good prognosis in patients with triple-negative breast cancer.

Authors:  Motoi Baba; Masato Takahashi; Katsushige Yamashiro; Hideki Yokoo; Moto Fukai; Masanori Sato; Mitsuchika Hosoda; Toshiya Kamiyama; Akinobu Taketomi; Hiroko Yamashita
Journal:  Surg Today       Date:  2015-10-22       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.